Chromium picolinate supplementation "beneficial" in type 2 diabetics in USDA study.
This article was originally published in The Tan Sheet
Executive Summary
CHROMIUM PICOLINATE ELEVATED INTAKE FOUND "BENEFICIAL" FOR DIABETICS in a study by Richard Anderson, PhD, U.S. Department of Agriculture, et al., in collaboration with Beijing Medical University. Published in the November issue of Diabetes, the research involved 180 subjects 35 to 65 with type 2 adult-onset diabetes. Patients received chromium picolinate in 200 mcg or 1,000 mcg doses daily or placebo. "Improvements in fasting glucose and insulin concentrations as well as those after a glucose challenge document the role of elevated intakes of supplemental chromium in the control of type 2 diabetes," the study says.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning